Taiwan har utvecklat ny H1N1-behandling

Pressmeddelande   •   Feb 03, 2010 13:23 CET


Government Information Office
Republic of China (Taiwan)

February 3, 2010


Taiwan develops new treatment for H1N1


The National Health Research Institutes (NHRI) and a research team from National Cheng Kung University Hospital (NCKUH) announced January 26 that they had discovered a new method for treating novel influenza (H1N1).

According to Su Ih-jen, deputy superintendent of NCKUH and leader of the research team, the team discovered that administering PPAR (peroxisome proliferators-activated receptor) agonists and antiviral drugs simultaneously could effectively treat H1N1 influenza, SARS (severe acute respiratory syndrome) and avian flu.

More than a decade ago, the research team began conducting a series of studies on virus-related hemophagocytic syndrome. After over three years of laboratory testing on animals, the results were published in the January 2010 edition of the biomedical journal Antiviral Therapy.

Su added that the treatment has been approved by the Center for Drug Evaluation of the Department of Health and the NHRI. Clinical tests have already begun this January at five major hospitals, including NCKUH and Kaohsiung Veterans General Hospital. These trials will focus on pneumonia resulting from influenza as well as treatment of the H1N1 flu. The research team hopes to have the new treatment ready for use by autumn or winter, in time for next wave of H1N1 infections.


Please visit Taiwan Today for related story:

New swine flu treatment method discovered (Jan. 27, 2010)